You are here

  • Home
  • Archive
  • Volume 5, Issue 2
  • Gemfibrozil reduced the risk for coronary events in men with coronary artery disease and low levels of high density lipoprotein cholesterol

Article info

Article menu
Download PDFPDF
Therapeutics
Gemfibrozil reduced the risk for coronary events in men with coronary artery disease and low levels of high density lipoprotein cholesterol
View Full Text

Citation

Gemfibrozil reduced the risk for coronary events in men with coronary artery disease and low levels of high density lipoprotein cholesterol
BMJ Evidence-Based Medicine 2000;5:49.

Publication history

  • First published March 1, 2000.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright 2000 by the ACP-ASIM and BMJ Publishing Group for Evidence-Based Medicine and by the ACP-ASIM for portions reproduced from ACP Journal Club